tiprankstipranks
Advertisement
Advertisement

HK:6622 Stock Latest News

Zhaoke Ophthalmology Sets 2026 AGM to Seek Share Repurchase and Issuance Mandates
Company AnnouncementsZhaoke Ophthalmology Sets 2026 AGM to Seek Share Repurchase and Issuance Mandates
6d ago
6622
Zhaoke Ophthalmology Moves to Update Articles for Hybrid Meetings and New HK Rules
PremiumCompany Announcements
Zhaoke Ophthalmology Moves to Update Articles for Hybrid Meetings and New HK Rules
14d ago
6622
Zhaoke Ophthalmology Narrows Core Loss as Revenue Halves in 2025
PremiumCompany Announcements
Zhaoke Ophthalmology Narrows Core Loss as Revenue Halves in 2025
1M ago
6622
Zhaoke Ophthalmology Schedules Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Zhaoke Ophthalmology Schedules Board Meeting to Approve 2025 Annual Results
2M ago
6622
Zhaoke Ophthalmology Set to Accelerate Asia-Pacific Launch After Partner’s FDA Approval for Presbyopia Drug
PremiumCompany Announcements
Zhaoke Ophthalmology Set to Accelerate Asia-Pacific Launch After Partner’s FDA Approval for Presbyopia Drug
3M ago
6622
Zhaoke Ophthalmology Expands BRIMOCHOL™ PF Presbyopia Push to Singapore and Vietnam
PremiumCompany AnnouncementsZhaoke Ophthalmology Expands BRIMOCHOL™ PF Presbyopia Push to Singapore and Vietnam
3M ago
6622
Zhaoke Ophthalmology’s Pediatric Myopia Drug Accepted for Evaluation by Australia’s TGA
Premium
Company Announcements
Zhaoke Ophthalmology’s Pediatric Myopia Drug Accepted for Evaluation by Australia’s TGA
4M ago
6622
Zhaoke Ophthalmology Partners with TSH Biopharm for Taiwan Market Entry
Premium
Company Announcements
Zhaoke Ophthalmology Partners with TSH Biopharm for Taiwan Market Entry
5M ago
6622
Zhaoke Ophthalmology Gains Key Approvals for Innovative Eye Treatments
PremiumCompany Announcements
Zhaoke Ophthalmology Gains Key Approvals for Innovative Eye Treatments
5M ago
6622
Zhaoke Ophthalmology Expands into Indonesia with New Distribution Agreement
PremiumCompany Announcements
Zhaoke Ophthalmology Expands into Indonesia with New Distribution Agreement
6M ago
6622
Zhaoke Ophthalmology Grants 8 Million Share Options to Boost Talent Retention
PremiumCompany Announcements
Zhaoke Ophthalmology Grants 8 Million Share Options to Boost Talent Retention
8M ago
6622
Zhaoke Ophthalmology Reports Significant Revenue Decline and Increased Losses in H1 2025
PremiumCompany Announcements
Zhaoke Ophthalmology Reports Significant Revenue Decline and Increased Losses in H1 2025
8M ago
6622
Zhaoke Ophthalmology Ltd. Schedules Board Meeting for Interim Results
PremiumCompany AnnouncementsZhaoke Ophthalmology Ltd. Schedules Board Meeting for Interim Results
9M ago
6622
Zhaoke Ophthalmology Secures Certification for Innovative Glaucoma Device
Premium
Company Announcements
Zhaoke Ophthalmology Secures Certification for Innovative Glaucoma Device
9M ago
6622
Zhaoke Ophthalmology Secures FDA Orphan Drug Designation for Pediatric Eye Cancer Treatment
Premium
Company Announcements
Zhaoke Ophthalmology Secures FDA Orphan Drug Designation for Pediatric Eye Cancer Treatment
9M ago
6622
Zhaoke Ophthalmology’s NVK002 Gains NMPA Acceptance for Myopia Treatment
PremiumCompany Announcements
Zhaoke Ophthalmology’s NVK002 Gains NMPA Acceptance for Myopia Treatment
10M ago
6622
Zhaoke Ophthalmology Updates Nomination Committee in Governance Code Compliance
PremiumCompany Announcements
Zhaoke Ophthalmology Updates Nomination Committee in Governance Code Compliance
10M ago
6622
Zhaoke Ophthalmology Announces Board Composition and Roles
PremiumCompany Announcements
Zhaoke Ophthalmology Announces Board Composition and Roles
10M ago
6622
Zhaoke Ophthalmology Establishes Nomination Committee for Board Appointments
PremiumCompany Announcements
Zhaoke Ophthalmology Establishes Nomination Committee for Board Appointments
10M ago
6622
Zhaoke Ophthalmology’s TAB014 BLA Accepted by China’s NMPA
PremiumCompany AnnouncementsZhaoke Ophthalmology’s TAB014 BLA Accepted by China’s NMPA
11M ago
6622
FDA Clears Zhaoke Ophthalmology’s IND Application for CsA Ophthalmic Gel
Premium
Company Announcements
FDA Clears Zhaoke Ophthalmology’s IND Application for CsA Ophthalmic Gel
11M ago
6622
Zhaoke Ophthalmology’s CsA Ophthalmic Gel NDA Accepted by NMPA
Premium
Company Announcements
Zhaoke Ophthalmology’s CsA Ophthalmic Gel NDA Accepted by NMPA
11M ago
6622

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >